Selected research
Market Structure
Global Pharmaceutical Polymer Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Polymer Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Polymer Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Polymer Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Polymer Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Polymer Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Polymer Excipients include Abitec Corporation, Accent Microcell, Archer Daniel Midland (ADM), Asahi Kasei, BASF, Cargill, Dow, Evonik and FMC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharmaceutical Polymer Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Polymer Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Polymer Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Polymer Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Polymer Excipients Segment by Company
Abitec Corporation
Accent Microcell
Archer Daniel Midland (ADM)
Asahi Kasei
BASF
Cargill
Dow
Evonik
FMC
Huzhou Zhanwang
Shandong Guangda Technology
Shandong Head
Tai'an Ruitai
Anhui Shanhe
Pharmaceutical Polymer Excipients Segment by Type
Starch
Polyethylene Glycol
Hydroxypropyl Methylcellulose (HPMC)
Micro Crystalline Cellulose (MCC)
Ethyl and Methyl Cellulose
Pharmaceutical Polymer Excipients Segment by Application
OSDF (Oral Solid Dosage Form)
Capsules
Other
Pharmaceutical Polymer Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Polymer Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Polymer Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Polymer Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Polymer Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Polymer Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Polymer Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Polymer Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Starch
- Polyethylene Glycol
- Hydroxypropyl Methylcellulose (HPMC)
- Micro Crystalline Cellulose (MCC)
- Ethyl and Methyl Cellulose
Applications
- OSDF (Oral Solid Dosage Form)
- Capsules
- Other
Companies covered
- Abitec Corporation
- Accent Microcell
- Archer Daniel Midland (ADM)
- Asahi Kasei
- BASF
- Cargill
- Dow
- Evonik
- FMC
- Huzhou Zhanwang
- Shandong Guangda Technology
- Shandong Head
- Tai'an Ruitai
- Anhui Shanhe
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Polymer Excipients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Polymer Excipients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharmaceutical Polymer Excipients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharmaceutical Polymer Excipients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharmaceutical Polymer Excipients Market Dynamics
- 2.1 Pharmaceutical Polymer Excipients Industry Trends
- 2.2 Pharmaceutical Polymer Excipients Industry Drivers
- 2.3 Pharmaceutical Polymer Excipients Industry Opportunities and Challenges
- 2.4 Pharmaceutical Polymer Excipients Industry Restraints
3 Pharmaceutical Polymer Excipients Market by Manufacturers
- 3.1 Global Pharmaceutical Polymer Excipients Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Polymer Excipients Sales by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Polymer Excipients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Polymer Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Polymer Excipients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Polymer Excipients Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Polymer Excipients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Polymer Excipients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Polymer Excipients Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Polymer Excipients Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Polymer Excipients Market by Type
- 4.1 Pharmaceutical Polymer Excipients Type Introduction
- 4.1.1 Starch
- 4.1.2 Polyethylene Glycol
- 4.1.3 Hydroxypropyl Methylcellulose (HPMC)
- 4.1.4 Micro Crystalline Cellulose (MCC)
- 4.1.5 Ethyl and Methyl Cellulose
- 4.2 Global Pharmaceutical Polymer Excipients Sales by Type
- 4.2.1 Global Pharmaceutical Polymer Excipients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Polymer Excipients Sales by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Polymer Excipients Sales Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Polymer Excipients Revenue by Type
- 4.3.1 Global Pharmaceutical Polymer Excipients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Polymer Excipients Revenue by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Polymer Excipients Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Polymer Excipients Market by Application
- 5.1 Pharmaceutical Polymer Excipients Application Introduction
- 5.1.1 OSDF (Oral Solid Dosage Form)
- 5.1.2 Capsules
- 5.1.3 Other
- 5.2 Global Pharmaceutical Polymer Excipients Sales by Application
- 5.2.1 Global Pharmaceutical Polymer Excipients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Polymer Excipients Sales by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Polymer Excipients Sales Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Polymer Excipients Revenue by Application
- 5.3.1 Global Pharmaceutical Polymer Excipients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Polymer Excipients Revenue by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Polymer Excipients Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Polymer Excipients Sales by Region
- 6.1 Global Pharmaceutical Polymer Excipients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Polymer Excipients Sales by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Polymer Excipients Sales by Region (2021-2026)
- 6.2.2 Global Pharmaceutical Polymer Excipients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Polymer Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Polymer Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Polymer Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharmaceutical Polymer Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharmaceutical Polymer Excipients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharmaceutical Polymer Excipients Revenue by Region
- 7.1 Global Pharmaceutical Polymer Excipients Revenue by Region
- 7.1.1 Global Pharmaceutical Polymer Excipients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharmaceutical Polymer Excipients Revenue by Region (2021-2026)
- 7.1.3 Global Pharmaceutical Polymer Excipients Revenue by Region (2027-2032)
- 7.1.4 Global Pharmaceutical Polymer Excipients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharmaceutical Polymer Excipients Revenue (2021-2032)
- 7.2.2 North America Pharmaceutical Polymer Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharmaceutical Polymer Excipients Revenue (2021-2032)
- 7.3.2 Europe Pharmaceutical Polymer Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharmaceutical Polymer Excipients Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharmaceutical Polymer Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharmaceutical Polymer Excipients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharmaceutical Polymer Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abitec Corporation
- 8.1.1 Abitec Corporation Company Information
- 8.1.2 Abitec Corporation Business Overview
- 8.1.3 Abitec Corporation Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abitec Corporation Pharmaceutical Polymer Excipients Product Portfolio
- 8.1.5 Abitec Corporation Recent Developments
- 8.2 Accent Microcell
- 8.2.1 Accent Microcell Company Information
- 8.2.2 Accent Microcell Business Overview
- 8.2.3 Accent Microcell Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Accent Microcell Pharmaceutical Polymer Excipients Product Portfolio
- 8.2.5 Accent Microcell Recent Developments
- 8.3 Archer Daniel Midland (ADM)
- 8.3.1 Archer Daniel Midland (ADM) Company Information
- 8.3.2 Archer Daniel Midland (ADM) Business Overview
- 8.3.3 Archer Daniel Midland (ADM) Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Archer Daniel Midland (ADM) Pharmaceutical Polymer Excipients Product Portfolio
- 8.3.5 Archer Daniel Midland (ADM) Recent Developments
- 8.4 Asahi Kasei
- 8.4.1 Asahi Kasei Company Information
- 8.4.2 Asahi Kasei Business Overview
- 8.4.3 Asahi Kasei Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Asahi Kasei Pharmaceutical Polymer Excipients Product Portfolio
- 8.4.5 Asahi Kasei Recent Developments
- 8.5 BASF
- 8.5.1 BASF Company Information
- 8.5.2 BASF Business Overview
- 8.5.3 BASF Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BASF Pharmaceutical Polymer Excipients Product Portfolio
- 8.5.5 BASF Recent Developments
- 8.6 Cargill
- 8.6.1 Cargill Company Information
- 8.6.2 Cargill Business Overview
- 8.6.3 Cargill Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cargill Pharmaceutical Polymer Excipients Product Portfolio
- 8.6.5 Cargill Recent Developments
- 8.7 Dow
- 8.7.1 Dow Company Information
- 8.7.2 Dow Business Overview
- 8.7.3 Dow Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dow Pharmaceutical Polymer Excipients Product Portfolio
- 8.7.5 Dow Recent Developments
- 8.8 Evonik
- 8.8.1 Evonik Company Information
- 8.8.2 Evonik Business Overview
- 8.8.3 Evonik Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Evonik Pharmaceutical Polymer Excipients Product Portfolio
- 8.8.5 Evonik Recent Developments
- 8.9 FMC
- 8.9.1 FMC Company Information
- 8.9.2 FMC Business Overview
- 8.9.3 FMC Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 FMC Pharmaceutical Polymer Excipients Product Portfolio
- 8.9.5 FMC Recent Developments
- 8.10 Huzhou Zhanwang
- 8.10.1 Huzhou Zhanwang Company Information
- 8.10.2 Huzhou Zhanwang Business Overview
- 8.10.3 Huzhou Zhanwang Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Huzhou Zhanwang Pharmaceutical Polymer Excipients Product Portfolio
- 8.10.5 Huzhou Zhanwang Recent Developments
- 8.11 Shandong Guangda Technology
- 8.11.1 Shandong Guangda Technology Company Information
- 8.11.2 Shandong Guangda Technology Business Overview
- 8.11.3 Shandong Guangda Technology Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shandong Guangda Technology Pharmaceutical Polymer Excipients Product Portfolio
- 8.11.5 Shandong Guangda Technology Recent Developments
- 8.12 Shandong Head
- 8.12.1 Shandong Head Company Information
- 8.12.2 Shandong Head Business Overview
- 8.12.3 Shandong Head Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Shandong Head Pharmaceutical Polymer Excipients Product Portfolio
- 8.12.5 Shandong Head Recent Developments
- 8.13 Tai'an Ruitai
- 8.13.1 Tai'an Ruitai Company Information
- 8.13.2 Tai'an Ruitai Business Overview
- 8.13.3 Tai'an Ruitai Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Tai'an Ruitai Pharmaceutical Polymer Excipients Product Portfolio
- 8.13.5 Tai'an Ruitai Recent Developments
- 8.14 Anhui Shanhe
- 8.14.1 Anhui Shanhe Company Information
- 8.14.2 Anhui Shanhe Business Overview
- 8.14.3 Anhui Shanhe Pharmaceutical Polymer Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Anhui Shanhe Pharmaceutical Polymer Excipients Product Portfolio
- 8.14.5 Anhui Shanhe Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Polymer Excipients Value Chain Analysis
- 9.1.1 Pharmaceutical Polymer Excipients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Polymer Excipients Production Mode & Process
- 9.2 Pharmaceutical Polymer Excipients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Polymer Excipients Distributors
- 9.2.3 Pharmaceutical Polymer Excipients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst